How Can Low-Dose Ketamine, a 'Lifesaving' Drug for Major Depression, Alleviate Symptoms Within Hours? Nov. 18, 2024 — Neuroscientists have identified the binding site of low-dose ketamine ...
It is the first drug to have an impact on the symptoms of manic depression since the introduction of lithium more than 50 years ago. In international trials over the past two years, daily doses of ...
Major depressive disorder (MDD) is a chronic and recurrent mental condition leading to huge impacts on direct and indirect personal and public medical costs. To overcome such a serious mental ...
UK biotech Compass Pathways is planning a $100 million US IPO as it seeks to further develop its depression treatment ... laid out its plans to develop the drug known as COMP360, which is a ...
Shares in Axsome Therapeutics have rocketed on FDA approval of its depression therapy Auvelity ... or selective serotonin reuptake inhibitor drugs can take weeks to elevate mood, placing severely ...
In June 2024, Health Canada committed to publishing a list of drugs that are critical to patients and vulnerable to shortages. The list will help drug shortage stakeholders focus their actions and ...
Healthline News reports on emerging research, new treatments, diet, exercise, and trending topics in health and wellness. All articles are written by our network of editors and contributors ...
If you're over 65, odds are you're taking at least five or six medications every day. Do you know what they're doing to your body? You probably don't, and your doctor might not either.
Patients were treated with escalating doses of escitalopram up to 50 mg for up to 32 weeks until they achieved remission (Montgomery–Asberg Depression Rating Scale [MADRS] ≤8) or failed to ...
Risk factors include high blood pressure, diabetic nerve damage, smoking, obesity, Peyronie's disease, depression, and even certain medications. An accurate diagnosis is needed to ensure the right ...